Research Topics
| G F SawayaSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Frequency of cervical smear abnormalities within 3 years of normal cytologyG F Sawaya
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143 0856, USA
Obstet Gynecol 96:219-23. 2000..To compare cervical screening outcomes associated with age and three screening intervals, 1, 2, and 3 years...- Cervical neoplasia risk in women provided hormonal contraception without a Pap smearG F Sawaya
Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA
Contraception 63:57-60. 2001..Future research should quantify more precisely the risks and benefits of the general application of this strategy on a population level... 
Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trialGeorge F Sawaya
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94118, USA
Obstet Gynecol 112:990-7. 2008..To estimate the effect of providing women with a latex diaphragm, lubricant gel, and male condoms (intervention) compared with condoms alone (control) on human papillomavirus (HPV) incidence and clearance...- A 21-year-old woman with atypical squamous cells of undetermined significanceGeorge F Sawaya
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
JAMA 294:2210-8. 2005 - Outcomes associated with cesarean section versus vaginal breech delivery at a university hospitalL M Hopkins
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143 0705, USA
J Perinatol 27:141-6. 2007..This study encompasses our previous studies (in 1987 and 1995) and extends our experience to 21 years... - Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health planGeorge F Sawaya
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Fracisco, 3333 California Street, Suite 335, San Francisco, California 94143 0856, USA
Acta Cytol 49:391-7. 2005..To estimate squamous cell cervical cancer incidence within 3.5 years of 1, 2 and > or = 3 consecutive, normal cytologic tests... - Discontinuation of postmenopausal hormone therapyDeborah Grady
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
Am J Med 118:163-5. 2005..For women who cannot tolerate even a slow taper, the value of symptom relief likely outweighs any increased risks due to HT use... - Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infectionsKaren K Smith-McCune
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA 94143 0128, USA
J Low Genit Tract Dis 10:213-8. 2006..We hypothesized that Replens gel used with a diaphragm would neither inhibit human papillomavirus (HPV) detection in cervical samples and chlamydia (CT) and gonorrhea (GC) detection in urine samples, nor affect cervical cytology quality... - Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trialDeborah Grady
University of California, San Francisco, and San Francisco VA Medical Center, San Francisco, California 94115, USA
Obstet Gynecol 109:823-30. 2007..To estimate the effect of the selective serotonin reuptake inhibitor sertraline on hot flush frequency and severity in perimenopausal and postmenopausal women... - MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trialDeborah Grady
University of California, San Francisco, San Francisco, CA 94115, USA
Menopause 16:458-65. 2009..To determine the optimal dose, safety, and efficacy of an estrogen receptor beta selective Chinese herbal extract, menopausal formula 101 (MF101), for treating hot flushes... 
Oophorectomy as a risk factor for coronary heart diseaseVanessa L Jacoby
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA 94115, USA
Am J Obstet Gynecol 200:140.e1-9. 2009..The objective of the study was to examine the relationship between bilateral oophorectomy (BSO) and risk of coronary heart disease (CHD)...- Pelvic examinations and access to oral hormonal contraceptionJillian T Henderson
Department of Obstetrics, Gynecology and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California, San Francisco, San Francisco, California, USA
Obstet Gynecol 116:1257-64. 2010..Our purpose was to investigate clinicians' requirements for pelvic examination and what may account for practice differences... - Cervical cancer screening continues to limit provision of contraceptionEleanor Bimla Schwarz
General Internal Medicine Section, Department of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94121, USA
Contraception 72:179-81. 2005..We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills... - Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infectionsKaren K Smith-McCune
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America
PLoS ONE 5:e10094. 2010..The objective of this study was to determine whether cervico-vaginal HPV infection increases the risk of HIV acquisition in women independent of other common STIs... - Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in ZimbabweEmily Fukuchi
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA
Sex Transm Dis 36:305-11. 2009..Little is known about the distribution of HPV types, independent risk factors of incidence and persistence, and patterns of persistence in sub-Saharan Africa... - Changes in cervical cancer incidence after three decades of screening US women less than 30 years oldPamela G Chan
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94122, USA
Obstet Gynecol 102:765-73. 2003..To examine incidence trends of invasive cervical carcinoma in US women less than 30 years old from 1973 to 1999 by histologic type... - Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesionsM Kuppermann
Department of Obstetrics, Gynecology and Reproductive Sciences, Medical Effectiveness Research Center for Diverse Populations, University of California San Francisco, 3333 California Street, San Francisco, CA 94143, USA
Gynecol Oncol 118:108-15. 2010..We measured and compared patient preferences (utilities) for scenarios with varying surveillance strategies and outcomes to inform guidelines and cost-effectiveness analyses of post-treatment surveillance options... - Hot flushes, coronary heart disease, and hormone therapy in postmenopausal womenAlison J Huang
Departments of Medicine, University of California, San Francisco, CA 94115, USA
Menopause 16:639-43. 2009..The aim of this study was to examine interactions between hot flushes, estrogen plus progestogen therapy (EPT), and coronary heart disease (CHD) events in postmenopausal women with CHD... - Advancing age and cervical cancer screening and prognosisG F Sawaya
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 94143, USA
J Am Geriatr Soc 49:1499-504. 2001..30, 95% confidence interval 0.75-2.28). CONCLUSION: The disproportionate burden of cervical cancer observed in older women appears to be largely attributable to lack of screening within the 3 years before diagnosis... - Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older womenAlison J Huang
Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
J Gen Intern Med 23:1324-9. 2008..Little is known about women's attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening... - Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectivenessJoy Melnikow
Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA
Obstet Gynecol 116:1158-70. 2010..To estimate outcomes and costs of surveillance strategies after treatment for high-grade cervical intraepithelial neoplasia (CIN)... - Risk of cervical cancer associated with extending the interval between cervical-cancer screeningsGeorge F Sawaya
Department of Obstetrics, Gynecology, and Reproductive Sciences, Department of Veterans Affairs and University of California, San Francisco, San Francisco, USA
N Engl J Med 349:1501-9. 2003.... - Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidenceF H Stewart
Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 3333 California St, Suite 335, San Francisco, CA 94143 0744, USA
JAMA 285:2232-9. 2001.... - Should routine screening Papanicolaou smears be done for women older than 65 years?George F Sawaya
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA
Arch Intern Med 164:243-5; discussion 247-8. 2004 - Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older womenGeorge F Sawaya
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA, USA
Am J Obstet Gynecol 200:40.e1-7. 2009..Guidelines support ending cervical cancer screening in women aged 65-70 years and older with previous normal testing, but little is known about older women's attitudes and beliefs about ending screening... - Association between cancer risk perception and screening behavior among diverse womenSue E Kim
Department of Medicine, Medical Effectiveness Research Center for Diverse Populations, University of California, San Francisco, 400 Parnassus Ave, A 405, Box 0856, San Francisco, CA 94143 0856, USA
Arch Intern Med 168:728-34. 2008..We measured the perception of breast, cervical, and colon cancer risks and screening in diverse women to examine the association between risk perception and screening behavior... - Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap testsShalini L Kulasingam
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
Obstet Gynecol 107:321-8. 2006..We estimated the cost-effectiveness of screening women with 3 or more prior normal tests compared with screening those with no prior tests... - Screening interval and risk of invasive squamous cell cervical cancerMarie Grisham Miller
Department of Quality and Utilization, Kaiser Permanente Medical Care Program, Oakland, California 94553, USA
Obstet Gynecol 101:29-37. 2003..Our findings need to be placed in the context of the low absolute risks of developing invasive cervical cancer during the first 3 years after a negative cervical smear before making policy recommendation... - Persistent hot flushes in older postmenopausal womenAlison J Huang
Department of Medicine, University of California San Francisco, USA
Arch Intern Med 168:840-6. 2008..To examine the prevalence, natural history, and predictors of hot flushes in older postmenopausal women... - Testing for human papillomavirus in women with abnormal pap smear resultsGeorge F Sawaya
JAMA 288:1350-1; author reply 1351-2. 2002 - Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screeningWalter Kinney
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Department of Quality and Utilization, and Division of Research, Kaiser Permanente Medical Care Program, Oakland, California, USA
Acta Cytol 47:167-71. 2003..CONCLUSION: Invasive adenocarcinomas and adenosquamous carcinomas of the cervix detected by screening are found at an earlier stage and are associated with lower disease-specific mortality than those not detected by screening... - Papanicolaou testing: when does more become less?George F Sawaya
Am J Med 118:159-60. 2005 - Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions laterGeorge F Sawaya
Ann Intern Med 148:557-9. 2008 - Cervical cancer screening among women without a cervixMona Saraiya
JAMA 292:1551; author reply 1551-2. 2004 - Current cervical neoplasia screening practices of obstetrician/gynecologists in the USMona Saint
Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, USA
Am J Obstet Gynecol 192:414-21. 2005..CONCLUSION: Most US obstetrician/gynecologists screen low-risk women often and indefinitely, despite national guidelines designed to minimize screening harms resulting from overtesting... - HPV vaccination--more answers, more questionsGeorge F Sawaya
N Engl J Med 356:1991-3. 2007 - Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantagesGeorge F Sawaya
Ann Intern Med 147:668-9. 2007 - Evidence-based medicine versus liquid-based cytologyGeorge F Sawaya
Obstet Gynecol 111:2-3. 2008 - Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statementNed Calonge
Ann Intern Med 149:185-91. 2008..Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation)... - Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statementNed Calonge
Ann Intern Med 149:43-7. 2008..Grade A recommendation.) Do not screen for asymptomatic bacteriuria in men and nonpregnant women. (Grade D recommendation.)... - Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statementNed Calonge
Ann Intern Med 148:846-54. 2008..B recommendation) Current evidence is insufficient to assess the balance of benefits and harms of routine screening in asymptomatic adults with blood pressure of 135/80 mm Hg or lower. (I statement)... - USPSTF recommendations for STI screeningDavid Meyers
U S Preventive Services Task Force, Agency for Healthcare Research and Quality Center for Primary Care, Prevention, and Clinical Partnerships, Rockville, Maryland 20850, USA
Am Fam Physician 77:819-24. 2008.... - Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statementDiana B Petitti
Ann Intern Med 148:759-65. 2008..Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.)... - Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statementNed Calonge
Ann Intern Med 149:627-37. 2008..D recommendation). The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer. (I statement)...